Pharma Stocks Outlook for the week (16-20.07.2012)


Pharma Stocks Outlook for the week (16-20.07.2012)

Stocks of pharmaceutical companies are seen trading in a range-bound manner next week. However, investors will eye Dr Reddy's Laboratories Ltd's Apr-Jun result to be detailed on Thursday. Sequentially, the company's net profit is seen rising 3% while its net sales are likely to fall by 4% over the Jan-Mar quarter.

In the next few trading sessions, shares of Cipla Ltd are seen trading with a positive bias and investors with a long horizon may enter the stock at around 332 rupees, with a target of 355 rupees. Near-term support for the stock is seen at 325 rupees.

Apart from stock-specific movement, the sector will take cues from the broader market in the next five trading sessions. India's wholesale price inflation for June, which will be detailed on Monday, is likely to set the mood for the domestic indices. Investors will also eye the Apr-Jun earnings of companies.

DISCLAIMER

The suggestions made herein are for information purposes and are not recommendations to any person to buy or sell any securities. The information is derived from various sources that are deemed to be reliable but its accuracy and completeness are not guaranteed.Our blog does not accept any liability for the use of this column. Readers of this column who buy or sell securities based on the information in this column are solely responsible for their actions. And we won't be liable or responsible for any legal or financial losses made by anyone .Any surfing and reading of the information available in this blog is the acceptance of this disclaimer.